Vivo Capital, LLC Q1 2024 Filing
Filed April 22, 2024
Portfolio Value
$1.3B
Holdings
42
Report Date
Q1 2024
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 8,418,093 | $360.3T | 28312320.49% | |
| 2 | GONGeron Corp | 27,225,292 | $89.8T | 7059996.18% | |
| 3 | HRMYHarmony Biosciences Holdings Inc | 2,606,247 | $87.5T | 6877240.96% | |
| 4 | SVASinovac Biotech Ltd. | 11,800,000 | $76.3T | 5999350.92% | |
| 5 | AVDLAvadel Pharmaceuticals PLC | 3,972,099 | $67.1T | 5271906.40% | |
| 6 | VRNAVerona Pharma PLC | 3,610,177 | $58.1T | 4564597.81% | |
| 7 | ALXOALX Oncology Holdings Inc | 4,220,048 | $47.1T | 3697517.47% | |
| 8 | DYNDyne Therapeutics Inc | 1,635,136 | $46.4T | 3647852.34% | |
| 9 | TERNTerns Pharmaceuticals Inc | 6,657,992 | $43.7T | 3432140.76% | |
| 10 | CATBUSDAstria Therapeutics Inc | 2,329,027 | $32.8T | 2575970.61% | |
| 11 | VRDNViridian Therapeutics Inc | 1,678,207 | $29.4T | 2309136.78% | |
| 12 | SLNSilence Therapeutics PLC | 1,105,454 | $23.9T | 1876343.72% | |
| 13 | OLMAOlema Pharmaceuticals Inc | 1,873,704 | $21.2T | 1666730.50% | |
| 14 | AVU0Adverum Biotechnologies, Inc. | 1,500,000 | $21.2T | 1666704.65% | |
| 15 | NVLSEURAlpine Immune Sciences Inc | 520,505 | $20.8T | 1634028.67% | |
| 16 | TARSTarsus Pharmaceuticals Inc | 565,550 | $20.6T | 1615449.59% | |
| 17 | VSTMVerastem Inc | 1,538,461 | $18.2T | 1426548.30% | |
| 18 | CRNXCrinetics Pharmaceuticals Inc | 350,000 | $16.4T | 1287433.08% | |
| 19 | COGTCogent Biosciences Inc | 2,244,941 | $15.1T | 1185474.45% | |
| 20 | SERASera Prognostics Inc | 1,650,440 | $15.0T | 1180209.51% | |
| 21 | RGLSRegulus Therapeutics Inc | 5,000,000 | $14.4T | 1131567.51% | |
| 22 | TRMLTourmaline Bio Inc. | 591,882 | $13.6T | 1065095.62% | |
| 23 | CMPSCompass Pathway PLC | 1,608,000 | $13.4T | 1051301.66% | |
| 24 | ORICOric Pharmaceuticals Inc | 849,681 | $11.7T | 918071.68% | |
| 25 | ENGNEngene Holdings Inc. | 678,705 | $11.5T | 904000.64% | |
| 26 | —Genetron Holdings Ltd | 2,708,056 | $10.9T | 856527.85% | |
| 27 | IOBTIO Biotech Inc | 6,173,439 | $10.7T | 839249.76% | |
| 28 | YB4PSavara Inc | 2,088,323 | $10.4T | 817231.34% | |
| 29 | ZLABZai Lab Ltd | 531,198 | $8.5T | 668708.62% | |
| 30 | DCTHDelcath Systems, Inc. | 1,666,746 | $8.0T | 624749.27% | |
| 31 | RZLTRezolute Inc | 2,797,704 | $7.1T | 560608.80% | |
| 32 | CMPXCompass Therapeutics Inc | 3,556,023 | $7.0T | 553283.55% | |
| 33 | TILInstil Bio Inc | 624,338 | $6.7T | 529860.42% | |
| 34 | QTTBQ32 Bio Inc. | 370,068 | $6.3T | 495529.05% | |
| 35 | BOLT1EURBolt Therapeutics Inc | 3,521,291 | $4.9T | 387389.54% | |
| 36 | UNCYUnicycive Therapeutics | 3,470,152 | $4.8T | 376309.85% | |
| 37 | ALLKGUSDAllakos Inc | 2,988,000 | $3.8T | 295848.33% | |
| 38 | ALGSAligos Therapeutics Inc | 3,547,030 | $3.5T | 273154.82% | |
| 39 | —DBV Technologies SA | 2,708,875 | $2.0T | 159458.14% | |
| 40 | CDXSCodexis, Inc | 388,144 | $1.4T | 106447.73% | |
| 41 | WHWKAadi Bioscience Inc | 509,572 | $1.2T | 93699.92% | |
| 42 | DTILPrecision Biosciences Inc | 4,675 | $63.4B | 4981.65% |